Cargando…
Towards a therapy for Angelman syndrome by reduction of a long non-coding RNA
Angelman syndrome (AS) is a single gene disorder characterized by intellectual disability, developmental delay, behavioral uniqueness, speech impairment, seizures, and ataxia(1,2). It is caused by maternal deficiency of the imprinted gene UBE3A, encoding an E3 ubiquitin ligase(3-5). All patients car...
Autores principales: | Meng, Linyan, Ward, Amanda J., Chun, Seung, Bennett, C. Frank, Beaudet, Arthur L., Rigo, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351819/ https://www.ncbi.nlm.nih.gov/pubmed/25470045 http://dx.doi.org/10.1038/nature13975 |
Ejemplares similares
-
Truncation of Ube3a-ATS Unsilences Paternal Ube3a and Ameliorates Behavioral Defects in the Angelman Syndrome Mouse Model
por: Meng, Linyan, et al.
Publicado: (2013) -
Disrupted neuronal maturation in Angelman syndrome-derived induced pluripotent stem cells
por: Fink, James J., et al.
Publicado: (2017) -
Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
por: Lee, Dongwon, et al.
Publicado: (2023) -
Angelman Syndrome and Angelman-like Syndromes Share the Same Calcium-Related Gene Signatures
por: Panov, Julia, et al.
Publicado: (2021) -
Epilepsy in patients with Angelman syndrome
por: Fiumara, Agata, et al.
Publicado: (2010)